Local Institution

Sumida-ku, Tokyo 1308575

0 studies enrolling now · 1 studies all time

What they study most

Hepatitis C

Studies at this site

• Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy — Completed